ArticleInternational journal of pharmaceutics2022

A new self-attenuated therapeutic influenza vaccine that uses host cell-restricted attenuation by artificial microRNAs.

Ke Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.